Actively Recruiting

Phase 4
Age: 18Years - 64Years
All Genders
NCT05851976

Duloxetine for LBP

Led by Montefiore Medical Center · Updated on 2025-12-02

120

Participants Needed

1

Research Sites

186 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This research study will help determine whether a medication called duloxetine can improve back pain. It is well documented that many participants who come to the ER with acute low back pain still have low back pain 3 months later. The investigator team will attempt to determine whether duloxetine can help prevent this.

CONDITIONS

Official Title

Duloxetine for LBP

Who Can Participate

Age: 18Years - 64Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Present to Emergency Department (ED) primarily for management of low back pain between the lower border of the scapulae and upper gluteal folds
  • Musculoskeletal cause of low back pain, excluding non-musculoskeletal causes like urinary tract infection or ovarian cysts
  • Discharged home from the ED (not admitted to hospital)
  • Age between 18 and 64 years
  • Non-radicular pain not radiating below the gluteal folds
  • Pain duration less than 2 weeks (336 hours)
  • Back pain occurring less than once per week before the current episode
  • Baseline Roland-Morris Disability Questionnaire score greater than 5 indicating functionally impairing back pain
Not Eligible

You will not qualify if you...

  • Not available for follow-up
  • Pregnant or breastfeeding
  • Chronic pain syndrome with moderate or severe pain on 50% or more days for at least 3 months
  • Allergy or intolerance to study medications
  • Contraindications to NSAIDs including hypersensitivity, peptic ulcer, gastrointestinal bleeding, severe heart failure (NYHA 2 or worse), uncontrolled blood pressure (>160/100), low kidney function (GFR <60 ml/min), current use of anticoagulants, cirrhosis or acute hepatitis
  • Contraindications to duloxetine including alcohol use disorder, chronic liver disease, chronic kidney disease, glaucoma, active use of medication for depression, PHQ-9 score greater than 10 or symptoms of depression or suicidal thoughts
  • PHQ-9 score greater than 4 with symptoms of feeling down, depressed, or hopeless

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Montefiore Medical Center

The Bronx, New York, United States, 10467

Actively Recruiting

Loading map...

Research Team

B

Benjamin Friedman, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Duloxetine for LBP | DecenTrialz